Brain tumors in children

Archives of Neurology

Volumn 56, Issue 4, 1999, Pages 421-425

  Packer, Roger J ^a,b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; LOMUSTINE; VINCRISTINE;

BRAIN TUMOR; CANCER COMBINATION CHEMOTHERAPY; CHILD; EMBRYONAL CARCINOMA; GLIOMA; HUMAN; MEDULLOBLASTOMA; NEUROECTODERM TUMOR; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SCHOOL CHILD; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

EID: 0032952260     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.56.4.421     Document Type: Review

References (16)

1. Smith MA, Freidlin B, Ries LA, Simon R. Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst. 1998; 90:1269-1277.
2. Preston-Martin S, Pogoda JM, Mueller BA, et al. Results from an international case-control study of childhood brain tumors: the role of pre-natal vitamin supplementation. Environ Health Perspect. 1998;106:887-892.
3. Evans AE, Jenkin RDI, Sposto R, et al. The treatment of medulloblastoma. JNeurosurg. 1990:72:572-582.
4. Scheurlen WG, Schwabe GC, Joos S, et aL Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome. J Clin Oncol. 1998:16:2478-2485.
5. Packer RJ, Sutton LfJ, Elterman R, et al. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNL) and vincristine chemotherapy. J Nsurosurg. 1994:81:690-698.
6. Deutsch M, Thomas PR, Krischer J, et al. Results of a prospective randomized trial comparing patients with low-stage medulloblastoma: a combined Children's Cancer Group-Pediatric Oncology Group study. Pediatr Neurosurg. 1996; 24:167-177.
7. Packer RJ, Goldwein JW, Boyett J, et al. Early results of reduced-dose radiotherapy plus chemotherapy for children v/ith nondisseminated medulloblastoma: a Children's Cancer Group study [abstract]. Ann Neurol. 1995; 58:518.
8. Mason WP, Grovas A, Halpern, et al. Intensive chemotherapy and bone marrov; rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol. 1998:16:210-221.
9. Duffner P, Horowitz ME, Krishner JP, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med. 1993:328:1725-1731.
10. Duffner P, Krischer JP, Horowitz ME, et al. Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: a Pediatric Oncology Group study. Ann NeuwI. 1998.44:313-316.
11. Rorke LB, Packer RJ, Siegel JA. Central nervous system atypical teratoid/ rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg. 1996:85:56-65.
12. Packer RJ, Boyett JM, Zimmerman RA, et al. Brain stem gliomas of childhood: outcome after treatment with 7800 cGy of hyperfractionated radiotherapy: a Children's Cancer Group phase I/II trial. Cancer. 1994:74:1827-1834.
13. Packer RJ, Ater J, Alien J, et al. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. JfJeurosurg. 1997: 86:747-754.
14. Sposto R, Ertel IM, Jenkin RDT, et al. The effectiveness of chemotherapy for treatment of high-grade astrocytoma in children: results of a randomized trial. J Heurooncol. 1989:7:165-171.
15. Finlay J, Boyett J, Yates A, et al. Randomized phase III trial in childhood high-grade astrocytomas comparing vincristine, lomustine and prednisone with eightdrug-in-one-day regimen. JClin Oncol. 1995:13:112-123.
16. Finlay JL, Goldman S, Wong MC, et al. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. J Clin Oncol. 1996:14:2495-2503.